PCRX
Pacira Biosciences, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website acira.com
- Employees(FY) 715
- ISIN US6951271005
Performance
-4.14%
1W
+13.45%
1M
+29.2%
3M
-32.67%
6M
-43.75%
YTD
-41.07%
1Y
Profile
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.
Technical Analysis of PCRX 2024-12-20
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-12-18 09:50
- 2024-12-17 19:00
PCRX: What does Argus have to say about PCRX?(Argus Research)
- 2024-12-11 08:05
- 2024-12-10 19:05
- 2024-12-10 19:00
PCRX: Raising target price to $16.00(Argus Research)
- 2024-12-06 08:00
- 2024-12-05 19:00
- 2024-12-03 19:00
PCRX: What does Argus have to say about PCRX?(Argus Research)
- 2024-12-03 07:30
Pacira Awarded New U.S. Patent Covering EXPAREL Composition(GlobeNewswire)
- 2024-12-02 18:30
Pacira Awarded New U.S. Patent Covering EXPAREL Composition(Globenewswire)
- 2024-11-29 09:50
- 2024-11-26 19:00
PCRX: What does Argus have to say about PCRX?(Argus Research)
- 2024-11-14 10:05
- 2024-11-13 21:05
- 2024-11-12 19:00
PCRX: Lowering target price to $13.00(Argus Research)
- 2024-11-12 08:00
- 2024-11-11 19:00
- 2024-11-11 06:28
Daily – Vickers Top Insider Picks for 11/11/2024(Argus Research)
- 2024-11-08 06:22
Daily – Vickers Top Insider Picks for 11/08/2024(Argus Research)
- 2024-11-07 10:09
- 2024-11-07 08:49
Q3 2024 Pacira Biosciences Inc Earnings Call(Thomson Reuters StreetEvents)
- 2024-11-07 06:27
Daily – Vickers Top Insider Picks for 11/07/2024(Argus Research)
- 2024-11-07 02:20
- 2024-11-06 16:10
Pacira: Q3 Earnings Snapshot(Associated Press Finance)
- 2024-11-06 16:00
- 2024-11-06 06:07
Daily – Vickers Top Insider Picks for 11/06/2024(Argus Research)
- 2024-11-06 03:00
- 2024-11-05 19:00
PCRX: What does Argus have to say about PCRX?(Argus Research)
- 2024-11-05 06:43
Daily – Vickers Top Insider Picks for 11/05/2024(Argus Research)
- 2024-11-04 18:55
Page 1 of 10
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.